Table 3.
Body Systems | Complaints | Reported in participants (n) | Baseline score [median (IQR)] | EOT score [median (IQR)] | p |
---|---|---|---|---|---|
Gastrointestinal system | Nausea | 12 | 2 (1.25–2) | 1 (1–1) | 0.005a |
Anorexia | 16 | 3 (3–3) | 1 (1–1.75) | <0.001a | |
Epigastric pain | 11 | 2 (2–2) | 1 (1–1) | 0.001a | |
Abdominal distention | 6 | 2 (2–2) | 1 (1–1) | 0.014a | |
Musculoskeletal system | Weakness | 16 | 2 (2–2) | 1 (1–1) | 0.005a |
Bodyache | 15 | 2 (1–2) | 1 (1–1) | 0.005a | |
Lumber Pain | 2 | 1 (1–1) | 1 (1–1) | 1.000 | |
Neurological system | Headache | 6 | 1.5 (1–2) | 1 (1–1) | 0.083 |
Dizziness | 11 | 1 (1–1) | 1 (1–1) | 0.157 | |
Numbness of hands | 7 | 2 (1–2) | 1 (1–2) | 0.083 | |
Respiratory system | Chest pain | 11 | 1 (1–2) | 1 (1–1) | 0.083 |
Dyspnea | 5 | 1 (1–1) | 1 (1–1) | 1.000 | |
Cough | 2 | 1.5 (1–0) | 1 (1–1) | 0.317 | |
Local complaint | Occupational Dermatitis | 11 | 2 (2–2) | 2 (1–2) | 0.083 |
Nose irritation | 3 | 1 (1–1) | 1 (1–1) | 1.000 | |
Eye irritation | 6 | 1 (1–1) | 1 (1–1) | 1.000 |
EOT- End of treatment, IQR- Inter Quartile range.
p < 0.05 (Level of significance).